Post-marketing safety of finerenone: a disproportionality analysis of the FDA adverse event reporting system
The analysis of the AE signals may contribute to minimizing the risks associated with its use.
Authors
- Yiyi Jin (ORCID: https://orcid.org/0000-0003-2984-1914)
- Suyan Zhu (ORCID: https://orcid.org/0009-0001-3920-185X)
- Miao Fan (ORCID: https://orcid.org/0000-0002-6675-1195)
- Xiaomeng Zheng
Institutions
- Ningbo University (CN)
- Ningbo University Affiliated Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1080/14740338.2024.2392006
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.35